Strategies for Management of Corneal Neovascularisation
NCT02594423
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Corneal Neovascularisation
Interventions
DEVICE:
Fine Needle Diathermy
DRUG:
Bevacizumab
Sponsor
University of Nottingham